Specialties – Page 26

Precision Lead Placement: How 4D Phenomics Digital Heart Models are Revolutionizing Cardiac Resynchronization Therapy

By MedXY 01/21/2026

The MAPIT-CRT trial demonstrates that using 4D cardiac MRI-generated digital heart models to guide lead placement significantly improves LVEF in heart failure patients compared to standard techniques, offering a safe and feasible precision medicine approach.

Neurology news Radiology

Drug-Coated Balloons Superior to Bare-Metal Stents in Preventing Restenosis for High-Grade Intracranial Atherosclerosis

By MedXY 01/21/2026

A multicenter randomized controlled trial demonstrates that drug-coated balloons significantly reduce 6-month restenosis and 1-year recurrent ischemic events compared to bare-metal stents in patients with symptomatic high-grade intracranial stenotic disease.

Neurology news Radiology

Drug-Coated Balloons Outperform Bare-Metal Stents in Reducing Restenosis for Symptomatic Intracranial Stenosis

By MedXY 01/21/2026

A multicenter RCT demonstrates that drug-coated balloon (DCB) angioplasty significantly reduces 6-month restenosis and 1-year recurrent ischemic events compared to bare-metal stenting in patients with high-grade symptomatic intracranial atherosclerotic disease.

Emergency Medicine news Orthopedics

Cast Immobilization is Non-inferior to Surgery for Unstable Weber B Ankle Fractures: Results from the SUPER-FIN Trial

By MedXY 01/21/2026

The SUPER-FIN randomized trial reveals that cast immobilization is a viable, non-inferior alternative to surgery for unstable Weber B ankle fractures with a congruent mortise, leading to fewer complications and avoiding unnecessary hardware removal procedures.

Neurology news

Edaravone Dexborneol Improves Functional Recovery Following Endovascular Thrombectomy: Primary Results from the TASTE-2 Trial

By MedXY 01/21/2026

The multicenter TASTE-2 trial reveals that edaravone dexborneol significantly increases the likelihood of functional independence at 90 days for acute ischaemic stroke patients undergoing thrombectomy, particularly those presenting with a clinical-radiological mismatch, while maintaining a safety profile comparable to placebo.

Neurology news Public Health

Targeting the Right Brain: Structural Subtyping and Vascular Profiles Predict Response to Lifestyle Interventions in Dementia Prevention

By MedXY 01/20/2026

A sub-analysis of the FINGER trial reveals that individuals with specific grey matter patterns and lower vascular risk derive the most structural brain benefit from multimodal lifestyle interventions, highlighting the potential for personalized dementia prevention strategies.

Gastroenterology Internal Medicine news

Mediterranean Diet Outperforms Traditional Dietary Advice for Irritable Bowel Syndrome: A Landmark Randomized Trial

By MedXY 01/20/2026

A randomized clinical trial published in the Annals of Internal Medicine reveals that the Mediterranean diet is superior to traditional dietary advice for managing IBS symptoms, offering a nutrient-dense, sustainable first-line intervention with a 62% clinical response rate.

Cardiology Diabetes & Endocrinology news

Six Months of Intermittent Fasting: Potent Lipid Lowering but Limited Impact on Vascular and Glycemic Markers

By MedXY 01/20/2026

A randomized controlled trial investigates the 6-month effects of intermittent fasting on overweight adults, revealing significant improvements in lipid profiles and body composition despite neutral effects on blood pressure and glucose metabolism, alongside novel transcriptomic insights into GLP-1 signaling.

Gastroenterology news Oncology

Interactive Mobile Coaching Improves Long-Term Quality of Life and Symptom Management After Gastrectomy

By MedXY 01/20/2026

A randomized controlled trial demonstrates that early interactive human coaching via a mobile app improves long-term quality of life, reduces dyspnea, and eases eating restrictions in postgastrectomy patients, particularly among younger and female populations, despite not meeting its primary one-month endpoint.

Gastroenterology news Pediatrics

Preoperative Nutritional Support Significantly Reduces Postoperative Enterocolitis in Children with Hirschsprung Disease: A Multicenter Randomized Controlled Trial

By MedXY 01/20/2026

A multicenter RCT demonstrates that preoperative nutritional support reduces the incidence of Hirschsprung-associated enterocolitis (HAEC) from 29.09% to 7.27%, offering a critical strategy for improving surgical outcomes in pediatric patients.

Cardiology news Psychiatry

Keto vs. Mediterranean: New Evidence on Which Diet Wins for Heart and Brain Health

By MedXY 01/20/2026

This article compares the Ketogenic and Mediterranean diets' impact on cardiovascular markers and mental health, highlighting results from two recent pilot studies on blood pressure and the gut-brain axis.

Gastroenterology Internal Medicine news

Is 2 Liters of PEG Necessary? Simplified Water Prep Proves Effective for Crohn’s Capsule Endoscopy

By MedXY 01/20/2026

A randomized trial demonstrates that a simplified bowel preparation using clear liquids and water offers comparable diagnostic yield and cleanliness to PEG-based regimens for Crohn’s disease capsule endoscopy, while significantly improving patient acceptability and comfort.

Family Medicine & Nutrition Gastroenterology news

Rifaximin Demonstrates Superior Adherence and Faster Symptom Relief Compared to Low FODMAP Diet in Irritable Bowel Syndrome

By MedXY 01/20/2026

Clinical trials reveal that Rifaximin provides faster symptom relief and significantly better adherence than the low FODMAP diet in IBS patients, while also potentially restoring lactase activity in those with small intestinal bacterial overgrowth.

Allergy & Immunology news Pediatrics

High-Dose Prenatal Vitamin D and Childhood Atopy: Why Maternal Smoking History Matters

By MedXY 01/20/2026

Recent findings from the COPSAC2010 trial and EDEN cohort suggest that high-dose prenatal vitamin D's protective effect against atopic dermatitis is significantly enhanced in children of mothers exposed to tobacco, highlighting a potential personalized prevention strategy for high-risk pregnancies.

news Oncology

Liposomal Irinotecan Offers New Hope for HER2-Negative Breast Cancer Brain Metastases: Insights from the PHENOMENAL Study

By MedXY 01/20/2026

The PHENOMENAL phase 2 study reveals that liposomal irinotecan (nal-IRI) achieves a 22% intracranial objective response rate in patients with HER2-negative breast cancer and brain metastases, addressing a critical unmet need in neuro-oncology despite modest overall survival benefits.

Diabetes & Endocrinology news

Pre-Meal Whey Protein: A Targeted Nutritional Intervention to Mitigate Postprandial Hyperglycemia in Gestational Diabetes

By MedXY 01/20/2026

A randomized controlled trial demonstrates that a 20g whey protein pre-load 30 minutes before breakfast significantly reduces postprandial glucose excursions and glycemic variability in women with gestational diabetes throughout the third trimester, offering a promising non-pharmacological management strategy.

Hematology-Oncology news Oncology

Adjuvant Carboplatin Integration Redefines Survival Standards in Early-Stage Triple-Negative Breast Cancer: Insights from the RJBC 1501 Phase III Trial

By MedXY 01/20/2026

The RJBC 1501 Phase III trial demonstrates that adding carboplatin to adjuvant EC-T chemotherapy significantly improves disease-free, distant disease-free, and overall survival in early-stage TNBC patients, despite a manageable increase in hematologic toxicities.

$Venetoclax-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: A Critical Appraisal of the Phase III CANOVA Study$

Hematology-Oncology news

Venetoclax-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: A Critical Appraisal of the Phase III CANOVA Study

By MedXY 01/20/2026

The Phase III CANOVA trial evaluated venetoclax-dexamethasone against pomalidomide-dexamethasone in t(11;14)-positive RRMM. While the primary endpoint of progression-free survival was not statistically met, the study revealed significant improvements in response rates and a numerical survival benefit, supporting biomarker-driven approaches in myeloma care.

news Oncology Pediatrics

Optimizing Anti-GD2 Immunotherapy: Dinutuximab Beta Redefines Survival in Relapsed and High-Risk Neuroblastoma

By MedXY 01/20/2026

Recent clinical trials establish dinutuximab beta as a cornerstone of neuroblastoma therapy, demonstrating significant survival benefits when combined with chemotherapy in relapsed cases, while clarifying that adding Interleukin-2 to standard consolidation increases toxicity without improving outcomes.

news Oncology

GSK-3β Inhibition with Elraglusib Shows Selective Activity and Biomarker Potential in Salivary Gland and Pancreatic Cancers

By MedXY 01/20/2026

Clinical trials evaluate elraglusib, a GSK-3β inhibitor, in salivary gland and pancreatic cancers. While results were mixed, findings highlight the importance of nuclear GSK-3β expression as a biomarker and the need for dose optimization to manage combination toxicities.